Oncternal Therapeutics In... (ONCT)
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 9:00 PM
Oncternal Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY00 | FY99 |
| Net Income | -39.48M | -44.17M | -31.33M | -17.23M | -34.19M | -38.42M | -30.44M | -17.72M | -18.7M | -39.41M | -42.11M | -45.91M | -33.29M | 15.29M | -46.26M | -51.78M | -40.36M | -35.51M | -36.84M | -22.35M | -14.19M | -11.87M | -3.81M | -750K |
| Depreciation & Amortization | n/a | -75K | 169K | 150K | n/a | 46K | 47K | 28K | 43K | 102K | 384K | 750K | 1.04M | 1.57M | 1.78M | 1.56M | -4.9M | -5.01M | -299K | -580K | 357K | 332K | 80K | 45K |
| Stock-Based Compensation | 7.5M | 7.43M | 5.88M | 1.56M | 507K | 2.2M | 3.15M | 2.96M | 2.62M | 4.43M | 3.73M | 2.65M | 4.23M | 4.89M | 5.17M | 3.71M | 2.04M | 1.26M | 639K | 804K | 550K | n/a | n/a | n/a |
| Other Working Capital | 3.04M | -1.03M | -2.12M | -1.95M | 2.25M | -4.01M | 2.23M | 1.15M | -897K | -2.81M | -3.85M | 3.64M | 1.18M | -1.43M | 5.95M | 53.68M | 5.18M | 27.47M | 800K | 61.3M | 12.78M | 827K | n/a | n/a |
| Other Non-Cash Items | -1.46M | 179K | 169K | -151K | 19.45M | 166K | 166K | 132K | 113K | 422K | 135K | 169K | -8.07M | -51.79M | -11.15M | -10.96M | 2.22M | 1.4M | 852K | 804K | 550K | n/a | 3.73M | 705K |
| Deferred Income Tax | n/a | n/a | -169K | -150K | n/a | n/a | n/a | -8.16M | -3.08M | 8.8M | -1.37M | n/a | 1.78M | 1.69M | n/a | 34K | -2.17M | -1.02M | -639K | -804K | -550K | n/a | n/a | n/a |
| Change in Working Capital | 1.27M | -69K | -1.3M | -1.68M | -2.51M | -3.34M | 3.62M | 1.99M | -1.03M | -3.1M | -4.75M | 5.23M | 1.23M | -2.18M | 4.45M | 54.5M | 5.53M | 27.42M | 1.47M | 6.45M | 290K | 981K | n/a | n/a |
| Operating Cash Flow | -32.16M | -36.7M | -26.59M | -17.5M | -16.75M | -39.35M | -23.46M | -20.78M | -20.04M | -28.76M | -43.97M | -37.11M | -33.09M | -30.53M | -46M | -2.92M | -37.63M | -11.46M | -34.82M | -15.67M | -13M | -10.55M | n/a | n/a |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -2K | -90K | -4K | -5K | -32K | -142K | -54K | -95K | -600K | -2.9M | -1.74M | -578K | -935K | -1.17M | -108K | -313K | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | 16.14M | n/a | -24.16M | -37.65M | -71.43M | -10.69M | n/a | 18.9M | -2.45M | -16.94M | -2.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -64.35M | -26.5M | n/a | n/a | n/a | -44.16M | -39.28M | -35.4M | -55.22M | -41.91M | -1.43M | -11.98M | -15.14M | -8.57M | -11.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 65M | n/a | n/a | n/a | n/a | 72.04M | 24.16M | 37.65M | 71.43M | 10.69M | 9.27M | 14.63M | 4.9M | 16.94M | 2.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -26.5M | n/a | n/a | -2.15M | 72.04M | 24.16M | 37.65M | 71.43M | 10.69M | 1.42M | 14.63M | 2.45M | 16.94M | 2.45M | n/a | -513K | -240K | -446K | -4.83M | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 651K | -26.5M | n/a | n/a | 16.14M | 27.88M | -15.13M | 2.15M | 16.21M | -31.22M | 9.24M | 21.41M | -10.3M | 8.28M | -9.43M | -2.9M | -1.74M | -578K | -1.38M | -6M | -108K | -313K | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 301K | n/a | n/a | n/a | n/a | n/a | -2K | -7K | -82K | -85K | -88K | -5K | -5K | -5K | -5K | -4K | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | -156K | -3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -455K | -3.44M | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 617K | 4K | 15K | -569K | -156K | -211K | n/a | -617K | 1.23M | 85K | 55K | 9K | 136K | 1.17M | 826K | n/a | n/a | -433K | -1.04M | 10.96M | n/a | n/a |
| Financial Cash Flow | 1.07M | 9.58M | 617K | 114.18M | 15K | 23.91M | 45.49M | 13.48M | n/a | 63.33M | 1.22M | 3K | 48.95M | 40.21M | 131K | 1.16M | 20M | 57.57M | 45.69M | 71.43M | 18.95M | 10.96M | n/a | n/a |
| Net Cash Flow | -30.45M | -53.62M | -25.97M | 96.69M | -594K | 12.44M | 6.91M | -5.15M | -3.82M | 3.35M | -33.52M | -15.7M | 5.56M | 17.96M | -55.29M | -4.67M | -19.37M | 45.54M | 9.49M | 49.76M | 5.84M | 91K | n/a | n/a |
| Free Cash Flow | -32.16M | -36.7M | -26.59M | -17.5M | -16.75M | -39.35M | -23.46M | -20.87M | -20.04M | -28.76M | -44M | -37.25M | -33.14M | -30.62M | -46.6M | -5.83M | -39.37M | -12.04M | -35.75M | -16.84M | -13.11M | -10.87M | n/a | n/a |